Alessandro Colapietro Selected Research

PBI-05204

1/2022	The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma.
1/2020	The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Colapietro Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 01/2016
13	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2017
10	Prostatic Neoplasms (Prostate Cancer) 12/2019 - 01/2016
4	Glioma (Gliomas) 01/2022 - 03/2019
3	Brain Neoplasms (Brain Tumor) 01/2022 - 05/2018
1	Wounds and Injuries (Trauma) 01/2020
1	Nasal Polyps (Nasal Polyp) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Neoplasm Metastasis (Metastasis) 12/2019
1	Osteolysis 12/2019
1	Neuroblastoma 11/2018
1	Prolactinoma (Prolactinomas) 08/2018
1	Pituitary Neoplasms (Pituitary Adenoma) 08/2018
1	Bone Diseases (Bone Disease) 04/2018
1	Pelvic Organ Prolapse 01/2018
1	Necrosis 05/2017
1	Inflammation (Inflammations) 01/2017

Drug/Important Bio-Agent (IBA)

3	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 05/2017
3	EphrinsIBA 01/2020 - 05/2018
3	Docetaxel (Taxotere)FDA Link 12/2019 - 12/2017
3	Cyclin D1IBA 12/2017 - 02/2016
3	Hormones (Hormone)IBA 12/2017 - 01/2016
3	AndrogensIBA 09/2016 - 02/2016
2	PBI-05204IBA 01/2022 - 01/2020
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 10/2019
2	trans-sodium crocetinate (crocetin)IBA 01/2020 - 01/2019
2	thiamine triphosphorate (TTP)IBA 01/2020 - 10/2019
2	EphA1 Receptor (Eph Receptor)IBA 01/2020 - 05/2018
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 01/2018
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 09/2016 - 02/2016
1	Cell-Penetrating PeptidesIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2022
1	Cardiac GlycosidesIBA 01/2022
1	oleandrinIBA 01/2022
1	ABTL0812IBA 01/2022
1	sulforaphaneIBA 10/2021
1	LuciferasesIBA 01/2020
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2020
1	Eph Family Receptors (Eph Receptors)IBA 01/2020
1	Erythropoietin FDA Link 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Collagen Type I (Type I Collagen)IBA 12/2019
1	E-SelectinIBA 12/2019
1	taxaneIBA 12/2019
1	Mechanistic Target of Rapamycin Complex 2IBA 10/2019
1	Therapeutic UsesIBA 10/2019
1	Angiogenesis InhibitorsIBA 10/2019
1	CurcuminIBA 09/2019
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 09/2019
1	Carotenoids (Carotene)IBA 01/2019
1	crocinIBA 01/2019
1	AntioxidantsIBA 01/2019
1	CSK Tyrosine-Protein KinaseIBA 11/2018
1	PyrimidinesIBA 11/2018
1	Fenofibrate (CiL)FDA LinkGeneric 08/2018
1	aryl hydrocarbon receptor-interacting proteinIBA 08/2018
1	X480IBA 04/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	tinostamustineIBA 01/2018
1	Bendamustine Hydrochloride FDA Link 01/2018
1	Advanced Glycation End ProductsIBA 01/2018
1	Alkylating AgentsIBA 01/2018
1	CollagenIBA 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	Testosterone (Sustanon)FDA Link 12/2017
1	Androgen Receptors (Androgen Receptor)IBA 12/2017
1	Chemokine CXCL12IBA 06/2017
1	QuinolonesIBA 05/2017
1	vosaroxinIBA 05/2017
1	Sunitinib (Sutent)FDA Link 01/2017
1	Bevacizumab (Avastin)FDA Link 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Nerve Growth Factor (NGF)IBA 07/2016
1	Azacitidine (5 Azacytidine)FDA Link 07/2016
1	AgarIBA 02/2016
1	MTOR InhibitorsIBA 01/2016
1	XL147IBA 01/2016
1	TOR Serine-Threonine KinasesIBA 01/2016
1	Sirolimus (Rapamycin)FDA Link 01/2016
1	XL765IBA 01/2016
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2016

Therapy/Procedure

7	Radiotherapy 01/2022 - 02/2016
7	Drug Therapy (Chemotherapy) 01/2020 - 01/2017
6	Therapeutics 01/2022 - 12/2017
2	Castration 12/2019 - 12/2017
1	Chemoprevention 01/2019
1	Subcutaneous Injections 04/2018
1	Aftercare (After-Treatment) 01/2017